Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension..
Curr Pharm Des. 19(21), 3766-72.
(2013). Colesevelam improves glycemic control and lipid management in inadequately controlled type 2 diabetes mellitus..
Nat Clin Pract Endocrinol Metab. 5(1), 16-7.
(2009). Endothelial function, arterial stiffness and lipid lowering drugs..
Expert Opin Ther Targets. 11(9), 1143-60.
(2007). Combination treatment in HBeAg-negative chronic hepatitis B..
World J Hepatol. 1(1), 43-7.
(2009). Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome..
Hum Reprod. 28(3), 785-93.
(2013). Elevated diastolic but not systolic blood pressure increases mortality risk in hypertensive but not normotensive patients with acute ischemic stroke..
Am J Hypertens. 28(6), 765-71.
(2015). Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management..
Nutr Metab Cardiovasc Dis. 20(2), 140-6.
(2010). Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity..
Cerebrovasc Dis. 41(5-6), 226-32.
(2016). Effects of lipid-lowering agents on inflammation, haemostasis and blood pressure..
Curr Pharm Des. 20(40), 6306-13.
(2014). Prior treatment with dipeptidyl peptidase 4 inhibitors is associated with better functional outcome and lower in-hospital mortality in patients with type 2 diabetes mellitus admitted with acute ischaemic stroke..
Diab Vasc Dis Res. 12(6), 463-6.
(2015). Persistent effect of zoledronic acid in Paget's disease..
Clin Exp Rheumatol. 25(3), 464-6.
(2007). Barriers to insulin treatment in patients with type 2 diabetes mellitus..
Expert Opin Pharmacother. 18(3), 233-234.
(2017). Treatment of congenital fibrinogen deficiency: overview and recent findings..
Vasc Health Risk Manag. 5, 843-8.
(2009). Cardiovascular Risk in Middle East Populations: A Call to Action..
Angiology. 66(9), 801-2.
(2015). Kidney function and estimated vascular risk in patients with primary dyslipidemia..
Open Cardiovasc Med J. 3, 57-68.
(2009). Type 2 diabetes is associated with a worse functional outcome of ischemic stroke..
World J Diabetes. 5(6), 939-44.
(2014). Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases..
Open Cardiovasc Med J. 5, 85-9.
(2011). The use of sibutramine in the management of obesity and related disorders: an update..
Vasc Health Risk Manag. 5(1), 441-52.
(2009). Response to "Brachial Systolic Blood Pressure Fails to Predict Short-Term Outcome in Patients With Acute Ischemic Stroke: What About Central Systolic Pressure?"..
Am J Hypertens. 28(9), 1181.
(2015). Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke..
Atherosclerosis. 243(1), 65-70.
(2015). Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke..
Clin Exp Hypertens. 39(3), 246-250.
(2017). Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients..
Mediators Inflamm. 2010, 364957.
(2010). Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke..
Blood Coagul Fibrinolysis. 27(2), 185-9.
(2016). The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia..
Curr Pharm Des. 23(10), 1495-1499.
(2017). Nonalcoholic fatty liver disease and statins..
Metabolism. 64(10), 1215-23.
(2015).